Novo Nordisk has gone up another gear in its drive to boost manufacturing ... injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in Novo Nordisk ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

Weight loss leader Novo Nordisk ... for Novo Nordisk as tariffs will increase prices. The company's key manufacturing facility is still in Denmark, though it does produce in the US too and with ...

Shares of Novo Nordisk closed around 1% lower on Thursday, while Eli Lilly's stock closed more than 11% lower. It comes as Novo Nordisk works to boost access ... across the US healthcare system ...

PLAINSBORO, N.J., April 25, 2025 /PRNewswire/ -- Yesterday, a Texas federal court ruled in favor of Novo Nordisk and FDA ... it is illegal under US compounding laws to make or sell knockoff ...

April 14 (Reuters) - Danish drugmaker Novo Nordisk NOVOb.CO said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being distributed outside its authorized supply chain ...

International Operations at Novo Nordisk. "By localising production, we are enhancing access to our life-changing medicines, enabling us to serve more people living with serious chronic diseases ...

In this article, we are going to take a look at where Novo Nordisk A/S ... in Brazil in a bid to boost the production of both Wegovy and Ozempic. Brazil is a major manufacturing destination ...

injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the US. The US Food and Drug Administration (FDA) has also updated its website with information about these ...

Oral pills, being more convenient than injectables, tend to boost patient adherence. Novo Nordisk also markets Rybelsus ... of the obesity market makes us believe that the setback is temporary.